Multiple sclerosis: longitudinal measurement of interleukin-1 receptor antagonist

Voltz, R; Hartmann, M; Spuler, S; Scheller, A; Mai, N; Hohlfeld, R; Yousry, T
February 1997
Journal of Neurology, Neurosurgery & Psychiatry;Feb1997, Vol. 62 Issue 2, p200
Academic Journal
No abstract available.


Related Articles

  • Multiple Sclerosis in Newfoundland and Labrador—A Model for Disease Prevalence. Sloka, J. S.; Prvse-Phillips, W. E. M.; Stefanelli, M. // Canadian Journal of Neurological Sciences;Feb2005, Vol. 32 Issue 1, p43 

    Focuses on a model of disease prevalence of multiple sclerosis (MS) in Newfoundland and Labrador. Genetic and environmental contributions to the prevalence of MS; Genetic aspects of MS etiology; Association of interleukin-1Beta and interleukin-1 receptor antagonist genes with disease severity.

  • Interleukin-1 Receptor Antagonist. Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p352 

    A definition of the term "Interleukin-1 Receptor Antagonist" is presented. It refers to an endogenous receptor antagonist for IL-1.

  • Scientific Session 12 Multiple Sclerosis immunology: Therapy with cytokines and anti-cytokines.  // Multiple Sclerosis (13524585);Jan99 Supplement 1, Vol. 5 Issue 1, pS16 

    Presents summaries of several studies on multiple sclerosis immunology. 'Why Did the TNF--Strategy Not Work?,' by A. Fontana; 'IL-12: Immunologic Staging of MS and a Measure of Response to Therapy,' by Howard Weiner, et al; 'Role of Interleukin-10 and Interleukin-12 in the Progression of...

  • Stool interleukin 1β and interleukin 1 receptor antagonist concentrations in children with active ulcerative colitis and during recovery. Wedrychowicz, Andrzej; Stopyrowa, Janina; Fyderek, Krzysztof; Miezynski, Witold // European Journal of Pediatrics;2003, Vol. 162 Issue 7/8, p541 

    Studies the measurement of interleukin-1 beta and interleukin 1 receptor antagonist (IL-1ra) ratios in stools of children with active ulcerative colitis (UC). Correlations with UC activity; Measurement of interleukin concentrations in the stool supernatants using commercial quantitative...

  • Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy.  // Current Medical Literature: Multiple Sclerosis;2013, Vol. 5 Issue 1, p21 

    A review of the article "Interleukin 6 receptor blockade in patients with neuromyelitis optica nonresponsive to anti-CD20 therapy" by I. Ayzenberg and colleagues which appeared in the periodical "Multiple Sclerosis" on March 1, 2013, is presented.

  • IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. Matesanz, Fuencisla; Caro-Maldonado, Alfredo; Fedetz, Maria; Fernández, Oscar; Milne, Roger; Guerrero, Miguel; Delgado, Concepción; Alcina, Antonio // Journal of Neurology;May2007, Vol. 254 Issue 5, p682 

    A letter to the editor is presented about a study on the significant association between interleukin 2 receptor alpha chain gene polymorphism and multiple sclerosis, using a case-control approach with samples collected from Caucasians in Spain.

  • Interleukin-1Beta, Interleukin-1 Receptor Antagonist Levels in Patients With Subacute Sclerosing Panencephalitis and the Effects of Different Treatment Protocols. Haspolat, Senay; Anlar, Banu; Kose, Gulsen; Coskun, Mesut; Yegin, Olcay // Journal of Child Neurology;Jun2001, Vol. 16 Issue 6, p417 

    Subacute sclerosing panencephalitis is a rare progressive inflammatory disease of the central nervous system caused by a persistent aberrant measles virus infection. Cytokines are polypeptides that regulate immune responses and inflammatory reactions. Interleukin-1β has been implicated as a...

  • Prostaglandin E2—EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion. Chengcan Yao; Sakata, Daiji; Esaki, Yoshiyasu; Youxian Li; Matsuoka, Toshiyuki; Kuroiwa, Kenji; Sugimoto, Yukihiko; Narumiya, Shuh // Nature Medicine;Jun2009, Vol. 15 Issue 6, p633 

    Two distinct helper T (TH) subsets, TH1 and TH17, mediate tissue damage and inflammation in animal models of various immune diseases such as multiple sclerosis, rheumatoid arthritis, inflammatory bowel diseases and allergic skin disorders. These experimental findings, and the implication of...

  • Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Smith, Terence; Groom, Anthony; Zhu, Bin; Turski, Lechoslaw // Nature Medicine;Jan2000, Vol. 6 Issue 1, p62 

    Multiple sclerosis is an immune-mediated disorder of the central nervous system leading to progressive decline of motor and sensory functions and permanent disability. The therapy of multiple sclerosis is only partially effective, despite anti-inflammatory, immunosuppresive and immunomodulatory...

  • ANAKINRA MAY ACCELERATE REDUCTION IN JOINT DESTRUCTION.  // Biotech Business;Dec2000, Vol. 13 Issue 12, p5 

    Focuses on the possible effect of anakinra or interleukin-1 receptor antagonist, on the joint damage progression of rheumatoid arthritis patients.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics